Brailer on health information ownership: Give it to patients

It's time to update health information policy and privacy rules, wrote former national coordinator for health IT David Brailer, MD, PhD, in an opinion piece in the Wall Street Journal.

The digitization of medical records removes the ownership of health data from individuals and places it in the hands of providers and healthcare organizations, he wrote. But, if patients don't have access to their data, that could disrupt care delivery.

HIPAA was written to protect paper records, Brailer wrote, so its applicability to the current digital landscape is unclear. "In the digital world, health information isn't 'stored' and locked away. It is online, constantly on the move, and accessible to hundreds of legitimate users."

Brailer offered the following four principles to guide new legislation:

1. Individuals should have total ownership of their health information, whenever they want. Individuals should be able to control who sees their information and whether those individuals or organizations can retain that information.

2. Individuals should be able to designate somebody to manage their information on their behalf, such as a spouse, hospital, health plan, pharmacy or a tech company. These intermediaries would be responsible for ensuring that the data are used to improve health status.

3. Raise standards for security protection and have those standards protect health information wherever it goes.

4. All covered entities interacting with health data should follow the same rules.

"The gold rush [for health data] is on," Brailer wrote. "Someone is going to benefit from the immeasurable wealth created from your health information and its capacity to extend and improve lives. It might as well be you."

Read the complete article.

 

 
Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.